Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus.
Wang J, Qi Z, Wu Y, Wang A, Liu Q, Zou F, Wang B, Qi S, Cao J, Hu C, Shi C, Liang Q, Wang L, Liu J, Wang W, Liu Q.
Wang J, et al. Among authors: wu y.
Signal Transduct Target Ther. 2023 Apr 5;8(1):143. doi: 10.1038/s41392-023-01352-4.
Signal Transduct Target Ther. 2023.
PMID: 37015918
Free PMC article.